Alexander O. Pasternak

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment control.

Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment control.

Journal: Current opinion in HIV and AIDS

Published: May 15, 2026

HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir.

HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir.

Journal: eLife

Published: January 23, 2026

Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV.

Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV.

Journal: eLife

Published: January 23, 2026

Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV.

Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

No associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals.

No associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals.

Journal: Frontiers in immunology

Published: May 14, 2025

Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.

Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.

Journal: Current HIV/AIDS reports

Published: January 21, 2025

Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption.

Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption.

Journal: AIDS (London, England)

Published: December 17, 2024

Inhibition of ALKBH5 demethylase of m6A pathway potentiates HIV-1 reactivation from latency.

Inhibition of ALKBH5 demethylase of m6A pathway potentiates HIV-1 reactivation from latency.

Journal: Virology journal

Published: November 04, 2024

Soluble markers of viral rebound and post-treatment HIV control.

Soluble markers of viral rebound and post-treatment HIV control.

Journal: Current opinion in HIV and AIDS

Published: October 11, 2024

Persistent HIV-1 transcription during ART: time to reassess its significance?

Persistent HIV-1 transcription during ART: time to reassess its significance?

Journal: Current opinion in HIV and AIDS

Published: March 19, 2024

Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence.

Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence.

Journal: Nature communications

Published: February 16, 2024

Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency.

Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency.

Journal: Nature communications

Published: November 08, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026